Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase NA 3Phase 1/2 3Phase 1 2Phase 4 1

Status

Not yet recruiting 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Tumor-Agnostic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Neoplasm, Residual 3

Interventions

blinatumomab 3Blood Specimen Collection 2Azacitidine 2venetoclax 1ivosidenib 1gilteritinib 1daratumumab 1avapritinib 1Transplantation 1Radiosurgery 1Neoadjuvant Therapy 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1Lenalidomide 1Interferon alpha-2 1Inotuzumab Ozogamicin 1Idarubicin 1High-Throughput Nucleotide Sequencing 1Daunorubicin 1Cytarabine 1Control Groups 1Consolidation Chemotherapy 1Chemotherapy, Adjuvant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Neoplasm, Residual × blinatumomab × Clear all
NCT07443592 2026-03-02

LAL-2025

PETHEMA Foundation

Phase NA Not yet recruiting
330 enrolled
LymphoidOther hematologic neoplasm

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07003737 2025-06-04

Blinatumomab Intensification for MRD-Negative Acute B-Cell Lymphoblastic Leukemia Before Allogeneic Hematopoietic Stem Cell Transplantation

First Affiliated Hospital of Zhejiang University

Phase NA Recruiting
114 enrolled
LymphoidOther hematologic neoplasm

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06763302 2025-01-08

NGS MRD-Guided Blinatumomab Treatment for Pediatric B-ALL

The Children's Hospital of Zhejiang University School of Medicine

Phase NA Not yet recruiting
1,220 enrolled
Tumor-Agnostic

Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon âš¡